These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
509 related items for PubMed ID: 19232299
1. Comparative performance of a combined injectable contraceptive (50 mg norethisterone enanthate plus 5mg estradiol valerate) and a combined oral contraceptive (0.15 mg levonorgestrel plus 0.03 mg ethinyl estradiol) in adolescents. Molina RC, Sandoval JZ, Montero AV, Oyarzún PG, Molina TG, González EA. J Pediatr Adolesc Gynecol; 2009 Feb; 22(1):25-31. PubMed ID: 19232299 [Abstract] [Full Text] [Related]
2. Continuous, daily levonorgestrel/ethinyl estradiol vs. 21-day, cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial. Teichmann A, Apter D, Emerich J, Greven K, Klasa-Mazurkiewicz D, Melis GB, Spaczynski M, Grubb GS, Constantine GD, Spielmann D. Contraception; 2009 Dec; 80(6):504-11. PubMed ID: 19913143 [Abstract] [Full Text] [Related]
3. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results. Kirkman RJ, Bromham DR, O'Connor TP, Sahota JE. Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652 [Abstract] [Full Text] [Related]
4. Monthly injectable contraceptive use by adolescents in Brazil: evaluation of clinical aspects. Guazzelli CA, Jacobucci MS, Barbieri M, Araújo FF, Moron AF. Contraception; 2007 Jul; 76(1):45-8. PubMed ID: 17586136 [Abstract] [Full Text] [Related]
5. Patient acceptability and satisfaction with Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension). Shulman LP, Oleen-Burkey M, Willke RJ. Contraception; 1999 Oct; 60(4):215-22. PubMed ID: 10640168 [Abstract] [Full Text] [Related]
6. Multicenter randomized comparative trial of two low-dose triphasic combined oral contraceptives containing desogestrel or norethindrone. Shoupe D. Obstet Gynecol; 1994 May; 83(5 Pt 1):679-85. PubMed ID: 8164925 [Abstract] [Full Text] [Related]
7. Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results. Archer DF, Jensen JT, Johnson JV, Borisute H, Grubb GS, Constantine GD. Contraception; 2006 Dec; 74(6):439-45. PubMed ID: 17157099 [Abstract] [Full Text] [Related]
8. A comparative study on the return to ovulation following chronic use of once-a-month injectable contraceptives. Bassol S, Hernandez C, Nava MP, Trujillo AM, Luz de la Cruz D. Contraception; 1995 May; 51(5):307-11. PubMed ID: 7628206 [Abstract] [Full Text] [Related]
9. Bleeding patterns of adolescents using a combination contraceptive injection for 1 year. Bortolotti de Mello Jacobucci MS, Guazzelli CA, Barbieri M, Araújo FF, Moron AF. Contraception; 2006 Jun; 73(6):594-7. PubMed ID: 16730490 [Abstract] [Full Text] [Related]
10. Effectivity and acceptability of oral contraceptives containing natural and artificial estrogens in combination with a gestagen. A controlled double-blind investigation. Serup J, Bostofte E, Larsen S, Westergaard J. Acta Obstet Gynecol Scand; 1981 Jun; 60(2):203-6. PubMed ID: 7018165 [Abstract] [Full Text] [Related]
11. Once-a-month injectable contraceptives. d'Arcangues C. World Health Forum; 1993 Jun; 14(4):439-40. PubMed ID: 8185807 [Abstract] [Full Text] [Related]
12. Controlled trial with a monthly combination injectable contraceptive in Europe. Brucker C. Gynecol Endocrinol; 2001 Aug; 15 Suppl 3():11-4. PubMed ID: 11570312 [Abstract] [Full Text] [Related]
13. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen. Sitruk-Ware RL, Menard J, Rad M, Burggraaf J, de Kam ML, Tokay BA, Sivin I, Kluft C. Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148 [Abstract] [Full Text] [Related]
14. Comparison of ovarian follicular activity during treatment with a monthly injectable contraceptive and a low-dose oral contraceptive. Jain JK, Ota F, Mishell DR. Contraception; 2000 Mar; 61(3):195-8. PubMed ID: 10827333 [Abstract] [Full Text] [Related]
15. Controlled trial with a monthly combination injectable contraceptive in the USA. Shulman LP. Gynecol Endocrinol; 2001 Aug; 15 Suppl 3():15-8. PubMed ID: 11570313 [Abstract] [Full Text] [Related]
16. Safety and bleeding profile of continuous levonorgestrel 90 mcg/ethinyl estradiol 20 mcg based on 2 years of clinical trial data in Canada. Reid RL, Fortier MP, Smith L, Mirkin S, Grubb GS, Constantine GD. Contraception; 2010 Dec; 82(6):497-502. PubMed ID: 21074011 [Abstract] [Full Text] [Related]
17. Menstrual pattern and lipid profiles during use of medroxyprogesterone acetate and estradiol cypionate and NET-EN (200 mg) as contraceptive injections. Canto de Cetina TE, Luna MO, Cetina Canto JA, Bassol S. Contraception; 2004 Feb; 69(2):115-9. PubMed ID: 14759615 [Abstract] [Full Text] [Related]
18. A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given by intramuscular injection to Chinese women. II. The comparison of bleeding patterns. Sang GW, Shao QX, Ge RS, Ge JL, Chen JK, Song S, Fang KJ, He ML, Luo SY, Chen SF. Contraception; 1995 Mar; 51(3):185-92. PubMed ID: 7621686 [Abstract] [Full Text] [Related]
19. Comparative study of the effects of two once-a-month injectable contraceptives (Cyclofem and Mesigyna) and one oral contraceptive (Ortho-Novum 1/35) on coagulation and fibrinolysis. United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulaion. Contraception; 2003 Sep; 68(3):159-76. PubMed ID: 14561536 [Abstract] [Full Text] [Related]
20. Comparative study of the effects of two once-a-month injectable steroidal contraceptives (Mesigyna and Cyclofem) on glucose metabolism and liver function. United Nations Development Programme/United Population Fund/World Health Organization/World Bank, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulation. Contraception; 1998 Feb; 57(2):71-81. PubMed ID: 9589832 [Abstract] [Full Text] [Related] Page: [Next] [New Search]